186 related articles for article (PubMed ID: 23518498)
1. A new function of the splicing factor SRSF2 in the control of E2F1-mediated cell cycle progression in neuroendocrine lung tumors.
Edmond V; Merdzhanova G; Gout S; Brambilla E; Gazzeri S; Eymin B
Cell Cycle; 2013 Apr; 12(8):1267-78. PubMed ID: 23518498
[TBL] [Abstract][Full Text] [Related]
2. Abnormal expression of the pre-mRNA splicing regulators SRSF1, SRSF2, SRPK1 and SRPK2 in non small cell lung carcinoma.
Gout S; Brambilla E; Boudria A; Drissi R; Lantuejoul S; Gazzeri S; Eymin B
PLoS One; 2012; 7(10):e46539. PubMed ID: 23071587
[TBL] [Abstract][Full Text] [Related]
3. Acetylation and phosphorylation of SRSF2 control cell fate decision in response to cisplatin.
Edmond V; Moysan E; Khochbin S; Matthias P; Brambilla C; Brambilla E; Gazzeri S; Eymin B
EMBO J; 2011 Feb; 30(3):510-23. PubMed ID: 21157427
[TBL] [Abstract][Full Text] [Related]
4. E2F1 controls alternative splicing pattern of genes involved in apoptosis through upregulation of the splicing factor SC35.
Merdzhanova G; Edmond V; De Seranno S; Van den Broeck A; Corcos L; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Cell Death Differ; 2008 Dec; 15(12):1815-23. PubMed ID: 18806759
[TBL] [Abstract][Full Text] [Related]
5. SRSF2 is required for sodium butyrate-mediated p21(WAF1) induction and premature senescence in human lung carcinoma cell lines.
Edmond V; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Cell Cycle; 2011 Jun; 10(12):1968-77. PubMed ID: 21555914
[TBL] [Abstract][Full Text] [Related]
6. E2F-1, Skp2 and cyclin E oncoproteins are upregulated and directly correlated in high-grade neuroendocrine lung tumors.
Salon C; Merdzhanova G; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Oncogene; 2007 Oct; 26(48):6927-36. PubMed ID: 17471231
[TBL] [Abstract][Full Text] [Related]
7. Human Papillomavirus 16 Oncoprotein Expression Is Controlled by the Cellular Splicing Factor SRSF2 (SC35).
McFarlane M; MacDonald AI; Stevenson A; Graham SV
J Virol; 2015 May; 89(10):5276-87. PubMed ID: 25717103
[TBL] [Abstract][Full Text] [Related]
8. The transcription factor E2F1 and the SR protein SC35 control the ratio of pro-angiogenic versus antiangiogenic isoforms of vascular endothelial growth factor-A to inhibit neovascularization in vivo.
Merdzhanova G; Gout S; Keramidas M; Edmond V; Coll JL; Brambilla C; Brambilla E; Gazzeri S; Eymin B
Oncogene; 2010 Sep; 29(39):5392-403. PubMed ID: 20639906
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of SRPK2 promotes cell cycle arrest though E2F1 in non-small cell lung cancer.
Li X; Yang S; Zhang M; Xie S; Xie Z
Eur J Histochem; 2019 Dec; 63(4):. PubMed ID: 31833327
[TBL] [Abstract][Full Text] [Related]
10. Activation of p27Kip1 Expression by E2F1. A negative feedback mechanism.
Wang C; Hou X; Mohapatra S; Ma Y; Cress WD; Pledger WJ; Chen J
J Biol Chem; 2005 Apr; 280(13):12339-43. PubMed ID: 15713665
[TBL] [Abstract][Full Text] [Related]
11. Depletion of SUMO ligase hMMS21 impairs G1 to S transition in MCF-7 breast cancer cells.
Ni HJ; Chang YN; Kao PH; Chai SP; Hsieh YH; Wang DH; Fong JC
Biochim Biophys Acta; 2012 Dec; 1820(12):1893-900. PubMed ID: 22906975
[TBL] [Abstract][Full Text] [Related]
12. The E2F transcription factor 1 transactives stathmin 1 in hepatocellular carcinoma.
Chen YL; Uen YH; Li CF; Horng KC; Chen LR; Wu WR; Tseng HY; Huang HY; Wu LC; Shiue YL
Ann Surg Oncol; 2013 Nov; 20(12):4041-54. PubMed ID: 22911364
[TBL] [Abstract][Full Text] [Related]
13. FOXO transcription factors control E2F1 transcriptional specificity and apoptotic function.
Shats I; Gatza ML; Liu B; Angus SP; You L; Nevins JR
Cancer Res; 2013 Oct; 73(19):6056-67. PubMed ID: 23966291
[TBL] [Abstract][Full Text] [Related]
14. Lysine acetyltransferase GCN5 potentiates the growth of non-small cell lung cancer via promotion of E2F1, cyclin D1, and cyclin E1 expression.
Chen L; Wei T; Si X; Wang Q; Li Y; Leng Y; Deng A; Chen J; Wang G; Zhu S; Kang J
J Biol Chem; 2013 May; 288(20):14510-14521. PubMed ID: 23543735
[TBL] [Abstract][Full Text] [Related]
15. MiR-15 and miR-16 are direct transcriptional targets of E2F1 that limit E2F-induced proliferation by targeting cyclin E.
Ofir M; Hacohen D; Ginsberg D
Mol Cancer Res; 2011 Apr; 9(4):440-7. PubMed ID: 21454377
[TBL] [Abstract][Full Text] [Related]
16. PTEN Physically Interacts with and Regulates E2F1-mediated Transcription in Lung Cancer.
Malaney P; Palumbo E; Semidey-Hurtado J; Hardee J; Stanford K; Kathiriya JJ; Patel D; Tian Z; Allen-Gipson D; Davé V
Cell Cycle; 2018; 17(8):947-962. PubMed ID: 29108454
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-493 suppresses tumor growth, invasion and metastasis of lung cancer by regulating E2F1.
Gu Y; Cheng Y; Song Y; Zhang Z; Deng M; Wang C; Zheng G; He Z
PLoS One; 2014; 9(8):e102602. PubMed ID: 25105419
[TBL] [Abstract][Full Text] [Related]
18. CUX1 and E2F1 regulate coordinated expression of the mitotic complex genes Ect2, MgcRacGAP, and MKLP1 in S phase.
Seguin L; Liot C; Mzali R; Harada R; Siret A; Nepveu A; Bertoglio J
Mol Cell Biol; 2009 Jan; 29(2):570-81. PubMed ID: 19015243
[TBL] [Abstract][Full Text] [Related]
19. E2F1-mediated upregulation of p19INK4d determines its periodic expression during cell cycle and regulates cellular proliferation.
Carcagno AL; Marazita MC; Ogara MF; Ceruti JM; Sonzogni SV; Scassa ME; Giono LE; Cánepa ET
PLoS One; 2011; 6(7):e21938. PubMed ID: 21765927
[TBL] [Abstract][Full Text] [Related]
20. E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C.
Sang XB; Zong ZH; Wang LL; Wu DD; Chen S; Liu BL; Zhao Y
Oncotarget; 2017 Feb; 8(9):14777-14793. PubMed ID: 28146423
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
